Myrtle Potter

Application by Alpine Partners (BVI) LP, of the British Virgin Islands, to take discovery from Sumitovant Biopharma Ltd., Sumitovant Biopharma, Inc., Myrtle Potter, Matthew Gline, Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC for use in an "appraisal proceeding" in Bermuda "concerning the take-private merger of Myovant Sciences Ltd.", filed at the U.S. District Court for the Southern District of New York.

Complaint in Adrienne Halbertsam v. Myovant Sciences Ltd., described as a Bermuda company based in London, England; Terrie Curan, Mark Gunan, Adele Gulfo, David Marek, Shigeyuki Nishinaka, Myrtle Potter, and Nancy Valente at the U.S. District Court for the Southern District of New York.

Complaint alleging securities fraud in Martin Schiffenbauer v. Myovant Sciences Ltd., described as a Bermuda "pharmaceutical company" based in London, England; Terrie Curran, Mark Guinan, Adele M. Gulfo, Dave Marek, Shigeyuki Nishinaka, Myrtle Potter, and Nancy Valente at the U.S. District Court for the Southern District of New York.

Complaint alleging the defendants made "untrue statements of fact and/or omitted material facts" in Claudia Cisneros v. Urovant Sciences Ltd., described as a Bermuda-domiciled "clinical-stage biopharmaceutical company" whose shares are listed on NASDAQ; James Robinson and whose parent is domiciled in the Cayman Islands; Myrtle Potter, James Hindman, SEF P Kurstjens, Pierre Legault, and Shigeyuki Nishinaka at the U. S. District Court for the Southern District of New York.